IRhythm Technologies EBITDA 2015-2025 | IRTC

IRhythm Technologies EBITDA for the quarter ending June 30, 2025 was $-0.011B, a 27.68% decline year-over-year.

  • IRhythm Technologies 2024 EBITDA was -0.088B, a 18.29% decline from 2023.
  • IRhythm Technologies 2023 EBITDA was -0.108B, a 14.2% increase from 2022.
  • IRhythm Technologies 2022 EBITDA was -0.095B, a 6.95% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

IRhythm Technologies EBITDA 2015-2025 | IRTC

  • IRhythm Technologies 2024 EBITDA was -0.088B, a 18.29% decline from 2023.
  • IRhythm Technologies 2023 EBITDA was -0.108B, a 14.2% increase from 2022.
  • IRhythm Technologies 2022 EBITDA was -0.095B, a 6.95% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$47.5B
Tempus AI (TEM)$14B
Doximity (DOCS)$12.7B
Hims & Hers Health (HIMS)$10.1B
Hinge Health (HNGE)$4.5B
Inspire Medical Systems (INSP)$2.8B
Privia Health (PRVA)$2.7B
Heartflow (HTFL)$2.4B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.8B
Phreesia (PHR)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$666M
Zepp Health (ZEPP)$580M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$485M
Talkspace (TALK)$469M
Butterfly Network (BFLY)$383M
Carlsmed (CARL)$346M
TruBridge (TBRG)$307M
Outset Medical (OM)$252M
SOPHiA GENETICS SA (SOPH)$244M
Health Catalyst (HCAT)$231M
Nyxoah SA (NYXH)$219M
KORU Medical Systems (KRMD)$203M